NorthWest Biotherapeutics Inc (NWBO)

[terry hallinan]

A good flack is not thoughtful, not subtle, not bothered in the slightest by inconsistency or outright lying.

Seems to me this board's fair-haired boy is being eaten alive by a hairless gnome for whom truth, decency and morality are obscure words in a dictionary.

Sad to say.

Your word for today is "gnomonic projection."

A gnomonic projection is a wonderful tool for navigation with every straight line providing a great circle. A hairless gnome like Adam Feuerstein can do wonders with such tools without even needing to do the calculations. It is in the genes.

I don't want to write about Northwest Biotherapeutics (NWBO) all the time. Honestly, there are better ways for me to spend my time, but every time CEO Linda Powers speaks, another truth bomb explodes and I'm forced to clean up the mess.

Feuerstein wouldn't know the truth if he met it in broad daylight but messes are his meat and potatoes.

Last September, Northwest Bio's guidance for the DC-Vax phase III study was, "potentially finishing enrollment by the late summer of next year." That implied this upcoming August, maybe into September if generous about summer's end.

"This year" implies ... this year! September? October? December? Powers will keep us guessing, just as she's done with the actual number of patients enrolled in the study to date, which is never disclosed. Results of the interim efficacy analysis announced last December are still MIA. And Powers disappeared any mention of the next interim analysis, which was supposed to take place after 88 patient deaths.

http://www.thestreet.com/story/12734171/1/northwest-bio-fuzzier-on-cancer-vaccine-study-patient-enrollment.html?puc=yahoo&cm_ven=YAHOO

Estimates of recruitment goals and other timelines are less reliable than longrange weather forecasts but have nothing to do with truthfulness.

Then again, how would Feuerstein know about either?

Best, Terry